Vimarsana
Biggest News Aggregation in the World

Page 29 - Andrew Baum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andrew Baum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andrew Baum Today - Breaking & Trending Today

Merck (MRK) Q1 2023 Earnings Call Transcript - Vimarsana News

Merck (MRK) Q1 2023 Earnings Call Transcript

MRK earnings call for the period ending March 31, 2023.

Source: fool.com
Health Care Roundup: Market Talk - Vimarsana News

Health Care Roundup: Market Talk

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0813 GMT – GSK…

Source: biztoc.com
Top Lawyers in Hollywood: Variety Legal Impact Report 2023 - Vimarsana News

Top Lawyers in Hollywood: Variety Legal Impact Report 2023

Meet Hollywood's top entertainment dealmakers and litigators of 2023.

Divided appeals court OK's violation of speedy trial law | Subscriber Content - Vimarsana News

Divided appeals court OK's violation of speedy trial law | Subscriber Content

Colorado's second-highest court last month declined to overturn a man's Arapahoe County convictions, while acknowledging the head of the Colorado Department of Corrections failed to follow a law designed to give detainees a speedy trial.

Citi upgrades Merck, says the pharma giant's drug pipeline is underappreciated - Vimarsana News

Citi upgrades Merck, says the pharma giant's drug pipeline is underappreciated

Citi upgraded Merck shares to buy and raised its price target to $130. The firm believes that Merck's drug pipeline is underappreciated by the market. 

Source: cnbc.com